Examkin

Patient Management

2074 questions

All types2,074Multiple choice1,048Multiple select393Matching221Ordering412
Question 1061Question →

A 62-year-old woman is admitted to the oncology ward for worsening respiratory distress. She has a history of stage IV non-small cell lung cancer with extensive malignant pleural effusions. On physical examination, she is alert and fully oriented but visibly tachypneic with a respiratory rate of 34/min, utilizing accessory muscles of respiration. Despite maximal supplemental oxygen via high-flow nasal cannula, she continues to experience severe air hunger.

During a discussion with the medical team, the patient clearly articulates her understanding that her cancer is progressive and terminal. She states, "I cannot endure this struggling anymore. Please give me medication to ease my breathing, even if it means I might pass away sooner." Recognizing her severe distress and clear decision-making capacity, the attending physician initiates a continuous intravenous infusion of fentanyl to palliate her dyspnea.

Shortly afterward, the patient's husband arrives. He becomes highly agitated upon seeing the infusion pump and demands that the fentanyl be stopped immediately. He insists, "Those strong drugs will shut down her lungs! She just needs a breathing tube temporarily so her body can heal."

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Continue the continuous opioid infusion and explain to the husband that his wife's autonomous decisions take precedence

Answer

Continue the continuous opioid infusion and explain to the husband that his wife's autonomous decisions take precedence.
The correct answer acknowledges two fundamental principles of palliative care and medical ethics: patient autonomy and the principle of double effect. First, the patient is alert, understands her condition, and clearly communicates her wishes, meaning she possesses full decision-making capacity. Therefore, her autonomous refusal of intubation and request for symptom palliation strictly override her husband's demands. Second, administering opioids (like fentanyl) to treat severe, refractory dyspnea at the end of life is the standard of care. Under the principle of double effect, providing such medication is ethically permissible because the physician's primary intent is to relieve suffering, even if a secondary, unintended consequence is respiratory depression that hastens death. The physician should continue the medically appropriate, patient-directed therapy while providing empathetic communication and support to the distressed husband.

Step-by-Step Solution

1
Assess the patient's clinical status and decision-making capacity.
The patient is alert, oriented, understands her terminal prognosis, and clearly articulates a rational choice to prioritize comfort over longevity. She possesses intact decision-making capacity.
Establishing capacity is the fundamental first step before determining who has the authority to make medical decisions.
2
Evaluate the ethical justification for the requested treatment.
The administration of opioids to treat severe dyspnea in a terminal patient is ethically and legally justified under the principle of double effect.
The primary intent is to relieve suffering (air hunger), even if there is a foreseeable, but unintended, secondary effect of hastening death.
3
Address the conflict between the capable patient and the family member.
The physician must honor the capable patient's wishes and gently but firmly inform the husband that the patient's autonomous directives supersede his requests.
Surrogate decision-makers have no legal or ethical authority to override the decisions of a patient who has intact decision-making capacity.

Key Concept

In patients with intact decision-making capacity, their autonomous choices regarding end-of-life care supersede the demands of family members. Furthermore, treating severe dyspnea with opioids is justified by the principle of double effect.
Estimated Time:1m 30s
Question 1062Question →

A 34-year-old woman comes to the clinic for a follow-up visit. Four weeks ago, she was diagnosed with Graves disease and was started on methimazole and propranolol. Today, she reports significant improvement in her symptoms; her palpitations have resolved, and she is sleeping much better. She has not experienced any fever or sore throat. Her blood pressure is 120/75120/75 mm Hg and her pulse is 7272/min. Physical examination reveals a mild, non-tender goiter but no tremors.

Laboratory results from today show:

Laboratory TestResultReference Range
TSH<0.01< 0.01 μ\muU/mL0.4−4.00.4-4.0 μ\muU/mL
Free T41.11.1 ng/dL0.9−1.70.9-1.7 ng/dL
Total T3120120 ng/dL80−20080-200 ng/dL

Which of the following is the most appropriate next step in the management of this patient's antithyroid therapy?

Show answer & explanation

Answer: Maintain the current dose of methimazole

Answer

Maintain the current dose of methimazole
The patient has Graves disease and was started on methimazole 4 weeks ago. She is now clinically euthyroid (resolution of palpitations, normal heart rate) and biochemically euthyroid based on her normal free T4 and total T3 levels. Her TSH remains suppressed, which is a classic and expected physiological response. After initiating treatment for hyperthyroidism, pituitary TSH secretion remains suppressed for several months, even after peripheral thyroid hormone levels (T3 and T4) have completely normalized. Therefore, the most accurate markers for monitoring initial response to antithyroid medications are free T4 and total T3, not TSH. Because her peripheral hormone levels are now within the normal range and she is asymptomatic, the current dose of methimazole is appropriate and should be maintained.

Step-by-Step Solution

1
Evaluate the patient's clinical status after 4 weeks of antithyroid therapy.
The patient is clinically euthyroid, as evidenced by a normal heart rate and complete resolution of palpitations.
Clinical response is an essential first indicator of treatment efficacy and tolerance.
2
Interpret the laboratory findings in the context of recent hyperthyroidism treatment.
Free T4 and total T3 have normalized, indicating adequate disease control, while TSH remains suppressed.
Following prolonged hyperthyroidism, pituitary recovery of TSH production lags significantly (often by months) behind the normalization of peripheral thyroid hormones.
3
Determine the appropriate adjustment to the medication regimen.
The current dose of methimazole should be maintained.
The patient has achieved the therapeutic goal (normalization of T3/T4) without overshooting into hypothyroidism. Adjusting the dose based on TSH at this stage would be inappropriate.

Key Concept

In the initial weeks of treating hyperthyroidism, TSH remains suppressed due to prolonged pituitary suppression; therefore, treatment efficacy and dose adjustments should be based on free T4 and total T3 levels, not TSH.
Estimated Time:1m 0s
Question 1063Question →

An 81-year-old man is evaluated on hospital day 5 to determine his readiness for discharge. He was originally admitted for urosepsis complicated by severe delirium. Over the past 48 hours, he has completed a course of intravenous antibiotics and transitioned to oral therapy. His mental status has returned to his baseline, and he is alert and oriented to person, place, and time. His vital signs are temperature 37.1°C (98.8°F), blood pressure 130/80 mm Hg, pulse 76/min, and respirations 16/min. The patient's laboratory results are within normal limits. Prior to admission, he lived with his 79-year-old wife and walked independently. Currently, he is profoundly deconditioned. He requires moderate physical assistance from two people for bed-to-chair transfers and cannot ambulate. A physical therapy evaluation indicates that he participates well but experiences severe fatigue, limiting his active therapy participation to a maximum of 45 minutes per day. Which of the following is the most appropriate disposition for this patient?

Show answer & explanation

Answer: Transfer to a skilled nursing facility

Answer

Transfer to a skilled nursing facility
The correct disposition is transfer to a skilled nursing facility (SNF). This patient has resolved his acute medical issue (urosepsis with delirium) and is medically stable, meaning he no longer requires an acute care hospital bed. However, he is profoundly deconditioned and unsafe to return home. Discharging him home would place an impossible and dangerous physical burden on his elderly wife, as he requires a two-person assist for basic transfers. Because he can only tolerate 45 minutes of physical therapy per day due to fatigue, he does not qualify for an inpatient rehabilitation facility (IRF), which strictly requires patients to participate in at least 3 hours of intensive therapy per day. An SNF provides the appropriate level of subacute medical supervision and a slower-paced rehabilitation program tailored to patients who cannot tolerate intensive IRF programs.

Step-by-Step Solution

1
Evaluate the patient's medical stability and need for acute medical care.
The patient is afebrile with normal vital signs, has transitioned to oral antibiotics, and his mental status is back to baseline.
This establishes that the patient no longer requires an acute hospital stay or long-term acute care.
2
Assess the patient's functional status and available social support.
The patient requires a two-person assist for transfers and lives only with his 79-year-old wife.
This determines that discharging home, even with home health services, is profoundly unsafe.
3
Determine the appropriate level of post-acute rehabilitation based on therapy tolerance.
The patient fatigues rapidly and can only tolerate up to 45 minutes of therapy per day.
This rules out an inpatient rehabilitation facility (which requires a 3 hour/day tolerance) and confirms a skilled nursing facility as the appropriate setting.

Key Concept

Appropriate selection of post-acute care settings based on medical stability, functional needs, therapy tolerance, and social support.
Question 1064Question →

A 67-year-old woman is hospitalized for an acute pulmonary embolism and has been receiving an intravenous unfractionated heparin infusion since admission. On hospital day 5, routine laboratory studies reveal a platelet count of 105,000/mm3105,000/mm^3, which is a significant decrease from her admission baseline of 260,000/mm3260,000/mm^3. Vital signs show temperature 37.1∘C37.1^\circ C (98.8∘F98.8^\circ F), blood pressure 128/76128/76 mmHg, heart rate 8888/min, and respiratory rate 1616/min. She denies any epistaxis, hematuria, or melena, and there is no evidence of active bleeding. However, she complains of new-onset right calf pain. Physical examination shows right calf swelling and erythema. Which of the following are appropriate next steps in the evaluation and management of this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Discontinue the unfractionated heparin infusion immediately; Initiate continuous intravenous argatroban; Order an enzyme-linked immunosorbent assay (ELISA) for heparin-PF4 antibodies

Answer

The appropriate next steps are to immediately discontinue the unfractionated heparin infusion, initiate an alternative non-heparin anticoagulant such as argatroban, and order a heparin-PF4 antibody immunoassay.
This patient presents with a classic presentation of Heparin-Induced Thrombocytopenia (HIT) Type 2, characterized by a platelet count drop of greater than 50% occurring 5-10 days after heparin initiation, alongside a new thrombotic event (right calf DVT).

The 4T's score is used to determine the pretest probability of HIT:

Parameter2 points1 point0 points
Thrombocytopenia>50% drop, nadir ≥20k30-50% drop or nadir <20k<30% drop
TimingDays 5-10>Day 10 or unknown<Day 4
ThrombosisNew confirmed thrombosisProgressive/recurrent DVTNone
oTher causesNone evidentPossibleDefinite
Because she has a high clinical probability based on her score, all forms of heparin must be immediately discontinued. Due to the extremely high risk of progressive thrombosis, an alternative non-heparin anticoagulant, such as the direct thrombin inhibitor argatroban, must be started empirically. Concurrently, a heparin-PF4 antibody immunoassay should be sent to confirm the diagnosis, though treatment must not be delayed while awaiting these results.

Step-by-Step Solution

1
Calculate the 4T's score to determine the pretest clinical probability of HIT.
The patient has a >50% platelet drop (2 points), timing of 5 days (2 points), and a new suspected thrombosis (2 points). This yields a high-probability score of 6-8 points.
Establishing the clinical probability of HIT dictates whether immediate intervention is required before laboratory confirmation is available.
2
Select the immediate management interventions for high-probability HIT.
Stop all heparin exposure and start a non-heparin anticoagulant (argatroban).
Heparin must be stopped to remove the immunologic trigger. However, alternative anticoagulation is still required due to the massive prothrombotic risk, evidenced by the new deep vein thrombosis.
3
Select the appropriate diagnostic test for confirmation.
Order a heparin-PF4 ELISA.
Confirmatory testing is necessary to guide long-term management and document the allergy, though it must not delay life-saving empirical treatment.

Key Concept

Management of Heparin-Induced Thrombocytopenia (HIT) Type 2
Estimated Time:1m 30s
Question 1065Question →

A 67-year-old biological male presents to the ambulatory clinic for a routine health maintenance evaluation. His medical history is notable for type 2 diabetes mellitus, essential hypertension, and mild osteoarthritis of the knees. His current medications include lisinopril, metformin, and atorvastatin.

He has a 45 pack-year smoking history but successfully quit smoking 17 years ago. He consumes one to two alcoholic beverages per week.

A comprehensive review of his preventive health record reveals the following:
- A screening colonoscopy performed at age 59, which revealed two 4-mm hyperplastic polyps in the sigmoid colon.
- A 2-dose series of the recombinant zoster vaccine completed at age 62.
- A single dose of the 20-valent pneumococcal conjugate vaccine (PCV20) administered at age 65.
- A seasonal inactivated influenza vaccine administered 2 weeks ago.
- A Tdap booster administered 5 years ago.

Vital signs show a blood pressure of 124/76 mmHg, heart rate of 70/min, respiratory rate of 14/min, and a body mass index of 28 kg/m². The physical examination is unremarkable.

Which of the following is the most appropriate next step in preventive care for this patient?

Show answer & explanation

Answer: One-time ultrasonography of the abdominal aorta

Answer

The most appropriate next step is a one-time ultrasonography of the abdominal aorta.
The correct answer is a one-time ultrasonography of the abdominal aorta. According to the United States Preventive Services Task Force (USPSTF), a one-time screening for an abdominal aortic aneurysm (AAA) with ultrasonography is recommended for all men aged 65 to 75 years who have ever smoked (defined as a lifetime history of at least 100 cigarettes). This patient is a 67-year-old male with a significant smoking history who has not yet been screened, making this the most appropriate next step in his preventive care. The risk of AAA rupture is significantly elevated in this demographic, and early surgical or endovascular repair of large aneurysms improves mortality.

Step-by-Step Solution

1
Analyze the patient's demographics and social history.
The patient is a 67-year-old male with a 45 pack-year smoking history who quit 17 years ago.
Age, biological sex, and specific details of smoking history (pack-years and years since quitting) dictate several major screening guidelines.
2
Evaluate the indication for abdominal aortic aneurysm (AAA) screening.
The patient meets criteria for a one-time AAA screening ultrasound.
The USPSTF recommends a one-time screening for AAA in men aged 65 to 75 years who have ever smoked (Grade B).
3
Rule out the need for lung cancer screening.
Low-dose computed tomography (LDCT) is not indicated.
Although he has a >20 pack-year history, he quit 17 years ago. The USPSTF stops recommending LDCT once a patient has not smoked for 15 years.
4
Rule out the need for other tests and vaccines presented in the options.
Colonoscopy, carotid ultrasound, and PPSV23 are not indicated.
His next colonoscopy is due at age 69 (10-year interval for distal hyperplastic polyps). Asymptomatic carotid screening is Grade D. His PCV20 vaccine at age 65 completed his pneumococcal requirements.

Key Concept

The USPSTF criteria for abdominal aortic aneurysm (AAA) screening versus lung cancer screening based on smoking history.
Question 1066Question →

A 68-year-old man is evaluated in the clinic for a 4-week history of worsening fatigue, unintentional weight loss of 4 kg4\text{ kg} (8.8 lb8.8\text{ lb}), and frequent palpitations. He has a history of ischemic cardiomyopathy with a left ventricular ejection fraction of 30%30\% and an implanted cardioverter-defibrillator (ICD) placed for secondary prevention of sustained ventricular tachycardia. His medications include amiodarone, which was started 2 years ago for frequent ICD shocks, as well as carvedilol, lisinopril, empagliflozin, and furosemide. Vital signs show a blood pressure of 130/80 mmHg130/80\text{ mmHg} and a heart rate of 95/min95/\text{min}. Physical examination reveals a fine resting tremor. The thyroid gland is normal in size, non-tender, and without palpable nodules. There is no exophthalmos. Laboratory studies reveal:

Laboratory TestResultReference Range
Thyroid-stimulating hormone (TSH)0.01 μU/mL0.01\text{ }\mu\text{U/mL}0.4−4.0 μU/mL0.4-4.0\text{ }\mu\text{U/mL}
Free T43.2 ng/dL3.2\text{ ng/dL}0.8−1.8 ng/dL0.8-1.8\text{ ng/dL}
Free T36.1 pg/mL6.1\text{ pg/mL}2.3−4.2 pg/mL2.3-4.2\text{ pg/mL}

Which of the following is the most appropriate next step in the evaluation of this patient's condition to guide pharmacological management?

Show answer & explanation

Answer: Color flow Doppler ultrasonography of the thyroid

Answer

The correct next step is to perform color flow Doppler ultrasonography of the thyroid to differentiate the subtype of amiodarone-induced thyrotoxicosis.
Amiodarone-induced thyrotoxicosis (AIT) presents a unique monitoring and management challenge due to the drug's high iodine content and long half-life. AIT is divided into Type 1 (hyperthyroidism due to the Jod-Basedow effect in a patient with underlying thyroid pathology) and Type 2 (destructive thyroiditis). Determining the correct subtype is strictly required before initiating therapy, as the treatments differ drastically: Type 1 requires thionamides (e.g., methimazole) to block hormone synthesis, whereas Type 2 requires glucocorticoids (e.g., prednisone) to reduce inflammation. Color flow Doppler ultrasonography is the diagnostic test of choice to differentiate the two; it demonstrates increased vascularity in Type 1 and decreased or absent vascularity in Type 2.

Step-by-Step Solution

1
Identify the primary clinical problem.
The patient has low TSH and elevated Free T4/T3 while taking amiodarone, confirming Amiodarone-Induced Thyrotoxicosis (AIT).
Amiodarone contains high amounts of iodine and can cause severe thyroid dysfunction.
2
Determine the diagnostic requirements for AIT management.
AIT must be classified as Type 1 (increased hormone synthesis due to underlying thyroid disease) or Type 2 (destructive thyroiditis) because the treatments are entirely different (methimazole for Type 1, glucocorticoids for Type 2).
Treating the wrong subtype leads to therapeutic failure and prolonged thyrotoxicosis.
3
Select the appropriate modality to differentiate AIT subtypes.
Color flow Doppler ultrasonography is chosen. It shows increased vascularity in Type 1 AIT and decreased or absent vascularity in Type 2 AIT.
Standard hyperthyroidism evaluations like Radioactive Iodine Uptake (RAIU) scans are ineffective here because amiodarone's iodine load saturates the gland, resulting in universally low uptake regardless of the AIT subtype.

Key Concept

Patients with Amiodarone-Induced Thyrotoxicosis (AIT) require color flow Doppler ultrasonography to differentiate between Type 1 (treated with thionamides) and Type 2 (treated with glucocorticoids) because standard radioactive iodine scans are invalidated by amiodarone's iodine load.
Question 1067Question →

A 51-year-old woman comes to the ambulatory clinic to establish care. She recently changed jobs and has not seen a healthcare provider in over seven years. The patient has no acute complaints today but notes she recently entered menopause, as her last menstrual period was 14 months ago. Her past medical history is notable for mild intermittent asthma. Her body mass index is 33 kg/m². She previously smoked one pack of cigarettes daily from age 20 until she successfully quit at age 42 (22 pack-year history). She consumes one glass of wine occasionally on weekends. Vital signs today are within normal limits. Physical examination reveals a well-appearing adult with no focal abnormalities. Which of the following preventive interventions are indicated for this patient during today's visit? (Select all that apply.)

Select all that apply

Show answer & explanation

Answer: Measurement of hemoglobin A1c; Non-contrast chest computed tomography; Primary high-risk human papillomavirus testing

Answer

The indicated interventions are measurement of hemoglobin A1c, non-contrast chest computed tomography, and primary high-risk human papillomavirus testing.
Measurement of hemoglobin A1c is indicated because the patient is between the ages of 35 and 70 and has a BMI classified as obese (≥30 kg/m²), meeting criteria for prediabetes and type 2 diabetes screening. Non-contrast chest computed tomography is required because she falls into the 50-80 age bracket, has accumulated a smoking history of ≥20 pack-years, and quit less than 15 years ago. Primary high-risk human papillomavirus (hrHPV) testing is indicated because routine cervical cancer screening (via primary hrHPV or co-testing every 5 years) is recommended for women aged 30 to 65, and she has not received preventive care in over seven years.

Step-by-Step Solution

1
Evaluate metabolic screening indications based on demographics.
The patient is 51 years old with a BMI of 33 kg/m².
Current USPSTF guidelines mandate diabetes screening for adults aged 35-70 with overweight or obesity.
2
Assess lung cancer screening eligibility.
She is 51, has a 22 pack-year smoking history, and quit 9 years ago.
Screening is required for adults aged 50-80 with at least a 20 pack-year history who quit within the last 15 years.
3
Determine cervical cancer screening status.
She is a 51-year-old woman who has not had any healthcare visits in over 7 years.
Standard screening intervals are 3 years for Pap testing alone or 5 years for primary hrHPV or co-testing, meaning she is overdue.
4
Identify non-indicated interventions.
Dual-energy x-ray absorptiometry and resting electrocardiography are not supported by guidelines for this asymptomatic patient.
She is under 65 without a known high-risk profile for osteoporotic fractures, and routine ECG is not indicated for asymptomatic, low-risk individuals.

Key Concept

Application of age- and risk-based preventive screening guidelines for cancer and metabolic disease in the ambulatory setting.
Question 1068Question →

A 76-year-old man with metastatic prostate cancer and stage 4 chronic kidney disease is admitted to the hospital for management of severe, intractable bone pain. He is started on escalating doses of oral morphine. Over the next 48 hours, his pain control improves, but he develops worsening confusion, visual hallucinations, and frequent myoclonic jerks in his upper extremities. The patient's daughter, who is his designated healthcare proxy, is very distressed by these new symptoms. She demands that all opioid medications be stopped immediately, stating they are "destroying his brain." The patient is currently disoriented to time and place and cannot participate in medical decision-making. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Discontinue oral morphine and initiate intravenous fentanyl

Answer

Discontinue oral morphine and initiate intravenous fentanyl.
The correct action is to discontinue the offending agent (morphine) and rotate to a different opioid that is safe in renal impairment, such as fentanyl. The patient is experiencing opioid-induced neurotoxicity (OIN), a well-known complication in patients with chronic kidney disease (CKD) who receive morphine. Morphine is hepatically metabolized into active metabolites, primarily morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G), which are excreted by the kidneys. In the setting of severe CKD, M3G accumulates, crosses the blood-brain barrier, and causes significant neuroexcitatory effects including myoclonus, hyperalgesia, hallucinations, and delirium. The most appropriate clinical step is to explain the phenomenon to the distressed healthcare proxy and switch the patient's analgesia to an opioid that lacks active, renally cleared toxic metabolites, such as fentanyl or methadone. This relieves the toxicity while continuing to palliate the patient's severe cancer pain.

Step-by-Step Solution

1
Identify the acute clinical syndrome based on the patient's new symptoms.
The new onset of confusion, visual hallucinations, and myoclonic jerks in the setting of recent opioid escalation points to opioid-induced neurotoxicity (OIN).
Recognizing OIN is crucial because it requires a specific modification of the analgesic regimen rather than simply adding antipsychotics.
2
Correlate the syndrome with the patient's underlying comorbidities.
The patient has stage 4 chronic kidney disease. Morphine is metabolized to morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G), which rely on renal clearance.
In CKD, the neuroexcitatory metabolite M3G accumulates, crossing the blood-brain barrier and causing the observed myoclonus and delirium.
3
Determine the most appropriate management for the patient and the surrogate's concerns.
The treatment for OIN is opioid rotation. A safe opioid for patients with severe renal impairment (like fentanyl or methadone) must be initiated.
Stopping all opioids as the daughter requested would precipitate a severe pain crisis and withdrawal. Educating the daughter while rotating to a renal-safe opioid like fentanyl addresses both the toxicity and the underlying pain.

Key Concept

Management of Opioid-Induced Neurotoxicity in Chronic Kidney Disease
Question 1069Question →

A 52-year-old man who is currently unhoused is evaluated for discharge on hospital day 5. He was admitted for a severe diabetic foot infection consisting of cellulitis and a 3-cm plantar ulcer, without evidence of osteomyelitis. During the hospitalization, he underwent sharp debridement of the ulcer and received intravenous antibiotics. The infection is now well-controlled, with resolving erythema and no purulence. The patient is transitioned to oral amoxicillin-clavulanate to complete a 14-day total course. He also requires daily cleaning of the ulcer with normal saline and application of a simple dry sterile dressing. His previously undiagnosed diabetes mellitus is now managed with a once-daily injection of basal insulin glargine, which he has learned to self-administer. The patient is fully independent with all activities of daily living, cognitively intact, and ambulates independently. However, the physician strongly advises him to minimize weight-bearing on the affected foot to allow the ulcer to heal. The patient usually sleeps at a congregate night-by-night emergency shelter that requires all clients to vacate the premises from 7:00 AM to 5:00 PM daily. Which of the following is the most appropriate care setting transition for this patient?

Show answer & explanation

Answer: Transfer to a medical respite care facility

Answer

Transfer to a medical respite care facility
The correct disposition is a medical respite care facility. Medical respite (or recuperative) care is specifically designed for individuals experiencing homelessness who are clinically stable enough to be discharged from an acute care hospital but remain too ill or frail to safely recover on the streets or in a standard emergency shelter. This patient's primary medical needs are offloading his diabetic foot ulcer, completing oral antibiotics, and adjusting to a new insulin regimen. Returning to a night-by-night shelter would force him to walk the streets for 10 hours a day, virtually guaranteeing wound deterioration and readmission. Medical respite provides a safe, 24/7 environment where he can rest, elevate his foot, and receive basic medical oversight.

Step-by-Step Solution

1
Identify the patient's acute medical needs.
The patient requires completion of oral antibiotics, daily simple wound care, and strict offloading (minimizing weight-bearing) of a plantar ulcer.
Establishing medical requirements is the first step in determining appropriate disposition acuity.
2
Assess the patient's functional status and skilled nursing needs.
The patient is independent in ADLs, self-administers insulin, and only requires simple daily dressings. He does not meet criteria for a Skilled Nursing Facility (SNF).
SNF admission requires complex skilled nursing or intensive daily rehabilitation, which this patient lacks.
3
Evaluate the patient's social environment against medical recommendations.
The patient is unhoused and uses a night shelter that forces daytime vacating. This precludes Home Health Agency visits and forces weight-bearing, directly contradicting the medical advice to offload the foot.
Social determinants of health directly impact the safety and feasibility of outpatient care plans.
4
Select the optimal care transition bridging the medical and social gaps.
Medical respite care is selected.
It provides the exact structural support needed (24-hour bed rest for offloading, medication storage, and basic oversight) without requiring acute inpatient or SNF-level acuity.

Key Concept

Medical respite care (recuperative care) is the appropriate disposition for unhoused patients who are too medically fragile to recover on the streets or in traditional shelters, but who do not have qualifying skilled needs for a SNF or acute inpatient hospitalization.
Estimated Time:1m 30s
Question 1070Question →

A 68-year-old woman is evaluated in the hospital on day 6 of an admission for a massive right lower extremity deep vein thrombosis. She has been treated with a continuous unfractionated heparin infusion since admission. Her past medical history includes hypertension, osteoarthritis, and type 2 diabetes mellitus. Today, she reports new-onset right arm pain and swelling at the site of a recently removed peripheral intravenous catheter.

Vital signs are within normal limits. Physical examination reveals a swollen, tender, and erythematous right upper extremity.

Laboratory TestPatient ResultReference Range
Hemoglobin12.4 g/dL12.0-15.5 g/dL
Platelet count85,000/mm³150,000-400,000/mm³
aPTT65 seconds60-80 seconds (therapeutic)
Serum creatinine1.1 mg/dL0.6-1.2 mg/dL

The patient's baseline platelet count on admission was 240,000/mm³.

Which of the following are appropriate next steps in the monitoring and management of this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Discontinue unfractionated heparin and initiate a direct thrombin inhibitor; Order an enzyme-linked immunosorbent assay for anti-platelet factor 4 antibodies

Answer

The correct steps are to immediately discontinue the unfractionated heparin, initiate a direct thrombin inhibitor, and order an enzyme-linked immunosorbent assay (ELISA) for anti-platelet factor 4 antibodies.
This patient has a classic presentation of heparin-induced thrombocytopenia (HIT), evidenced by a >50% drop in platelets occurring 5 to 10 days after heparin initiation, alongside a new thrombotic event (suspected upper extremity DVT). Because HIT is a highly prothrombotic state driven by immune-complex mediated platelet activation, all heparin exposure must end immediately, and alternative anticoagulation (such as argatroban or bivalirudin) must be started empirically without waiting for lab results. The appropriate initial diagnostic test is the highly sensitive PF4 ELISA, rather than the more specific but time-consuming serotonin release assay.

Step-by-Step Solution

1
Calculate the 4T score to determine the clinical probability of heparin-induced thrombocytopenia (HIT).
The patient has a platelet drop >50% (2 points), timing between days 5-10 (2 points), new suspected thrombosis (2 points), and no other obvious causes (2 points), yielding a high-probability score of 8.
A high clinical suspicion dictates immediate empiric management changes before laboratory confirmation is available.
2
Select the appropriate immediate pharmacologic intervention.
Discontinue unfractionated heparin and initiate a non-heparin anticoagulant, such as a direct thrombin inhibitor (e.g., argatroban).
Continuing heparin or switching to low-molecular-weight heparin will fuel the immune-mediated platelet activation, while stopping all anticoagulation fails to protect against the high risk of new thromboses.
3
Select the appropriate initial diagnostic laboratory test to evaluate the complication.
Order a screening PF4 antibody ELISA.
The ELISA is rapid and highly sensitive, making it the ideal first-line test in the diagnostic sequence for HIT, to be followed by a confirmatory functional assay if positive.

Key Concept

Evaluation and management of Heparin-Induced Thrombocytopenia (HIT)

Alternative Method

In cases where direct thrombin inhibitors like argatroban are unavailable or contraindicated (e.g., severe hepatic impairment), fondaparinux or bivalirudin may be utilized as alternative non-heparin anticoagulants for HIT management.
Estimated Time:2m 0s
Question 1071Question →

An 82-year-old woman with advanced Lewy body dementia is admitted to the intensive care unit with septic shock secondary to aspiration pneumonia. Over the past 48 hours, despite maximal vasopressor support and targeted antimicrobial therapy, she has developed progressive multiorgan failure, including anuric acute kidney injury and severe lactic acidosis. She is completely unresponsive to noxious stimuli, and the medical team determines her condition is terminal. She does not have a formal advance directive or a designated healthcare proxy.

Her family is present at the bedside. Her husband of 50 years, who resides in an assisted living facility due to mild cognitive impairment, clearly and consistently articulates that his wife "never wanted to be kept alive by machines with no hope of recovery." He requests the withdrawal of all life-sustaining treatments. Her oldest son, who just arrived from out of state, demands that continuous renal replacement therapy be initiated immediately, arguing that his father's memory issues invalidate his decision-making ability.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Acknowledge the husband as the primary surrogate and transition to comfort-focused care

Answer

Acknowledge the husband as the primary surrogate and transition to comfort-focused care
The most appropriate action is to honor the husband's decision and transition the patient to comfort-focused care. In the absence of a formal advance directive or designated healthcare proxy, the legal hierarchy of surrogate decision-makers universally places the spouse at the top, ahead of adult children. Although the husband has mild cognitive impairment, clinical decision-making capacity is decision-specific. Because he demonstrates the ability to understand the medical situation, articulate a clear choice, and apply his wife's known values to the current scenario, he retains the clinical capacity to act as her surrogate. The son's demands cannot override the legally recognized primary surrogate.

Step-by-Step Solution

1
Evaluate the patient's clinical status and prognosis.
The patient is in terminal multiorgan failure with no realistic chance of meaningful recovery.
Establishing the medical reality is required before discussing goals of care and withdrawal of support.
2
Determine the appropriate surrogate decision-maker according to legal hierarchy.
The husband is the legal next of kin and primary surrogate, superseding the adult children.
In the absence of a designated proxy or advance directive, state laws universally place the spouse at the top of the surrogate hierarchy.
3
Assess the surrogate's clinical decision-making capacity.
Despite having mild cognitive impairment, the husband demonstrates a clear understanding of the medical facts and applies the patient's known values to the decision.
Capacity is decision-specific; mild dementia does not automatically preclude the ability to make medical decisions on behalf of another if the criteria for capacity are met.

Key Concept

In the absence of an advance directive, the spouse holds the highest priority as surrogate decision-maker. Mild cognitive impairment does not automatically invalidate a surrogate's clinical capacity, which is determined by a physician based on the individual's ability to understand the situation and articulate a choice consistent with the patient's values.
Question 1072Question →

During an annual health maintenance visit, a 66-year-old man inquires about due screening tests. He has a history of mild knee osteoarthritis managed with intermittent ibuprofen. His last colonoscopy, performed 5 years ago, was unremarkable. At last year's visit, he received the 20-valent pneumococcal conjugate vaccine (PCV20) and completed his recombinant zoster vaccine series. Recent laboratory studies, including a lipid panel and hemoglobin A1c, are within normal limits. The patient mentions that he briefly smoked cigarettes during a single summer while in college, estimating he consumed roughly ten packs in total before quitting permanently. He currently drinks one glass of wine weekly and walks daily. Vital signs and physical examination show no abnormalities. Which of the following is the most appropriate preventive intervention for this patient at this time?

Show answer & explanation

Answer: Screening ultrasonography of the abdomen

Answer

Screening ultrasonography of the abdomen
This patient is a 66-year-old man who smoked approximately 10 packs of cigarettes (200 cigarettes) in his lifetime. The USPSTF recommends a one-time screening for abdominal aortic aneurysm (AAA) with ultrasonography in men aged 65 to 75 years who have ever smoked. The term 'ever smoked' is strictly defined as having consumed 100 or more cigarettes over a lifetime. Because this patient meets both the age and smoking history criteria, a one-time screening abdominal ultrasound is the most appropriate next step.

Step-by-Step Solution

1
Identify the patient's demographic profile and specific risk exposures.
The patient is a 66-year-old male with a history of smoking 10 packs of cigarettes (equivalent to 200 cigarettes) in his lifetime.
Preventive screening guidelines are heavily dependent on age, biological sex, and specific exposures like tobacco use.
2
Evaluate the criteria for Abdominal Aortic Aneurysm (AAA) screening.
The USPSTF recommends a one-time screening ultrasound for AAA in men aged 65 to 75 who have 'ever smoked'.
Because 'ever smoked' is clinically defined as ≥100\geq 100 lifetime cigarettes, this patient (who smoked 200 cigarettes) qualifies for this screening.
3
Rule out the other screening and immunization options based on current status and guidelines.
Lung cancer screening is excluded (requires ≥20\geq 20 pack-years), FIT is excluded (within the 10-year colonoscopy interval), PPSV23 is excluded (already fully vaccinated with PCV20), and DEXA is excluded (low-risk male).
Ruling out distractors ensures the chosen intervention does not conflict with updated evidence-based intervals and indications.

Key Concept

The USPSTF recommends a one-time screening for abdominal aortic aneurysm (AAA) with ultrasonography in men aged 65 to 75 years who have ever smoked, which is strictly defined as having smoked 100 or more cigarettes in their lifetime.
Estimated Time:1m 30s
Question 1073Question →

Evaluate the following patient clinical profiles and pair each individual with the most appropriate, guideline-concordant preventive care intervention.

Click a left item, then click its matching right item

Items

A 54-year-old man who smoked one and a half packs of cigarettes daily for twenty years and achieved complete abstinence eight years ago
A 61-year-old postmenopausal woman with a body mass index of 19 kg/m² and a history of daily heavy alcohol consumption
A 43-year-old woman with an unremarkable medical and family history who is requesting an update on routine health maintenance
A 48-year-old man recently diagnosed with stage 3 chronic kidney disease who has no prior adult vaccination records beyond seasonal influenza

Matches

Show answer & explanation

Answer

Match the 54-year-old former smoker with low-dose computed tomography; the 61-year-old woman with low BMI with a DEXA scan; the 43-year-old average-risk woman with biennial mammography; and the 48-year-old with chronic kidney disease with the 20-valent pneumococcal conjugate vaccine.
Each patient precisely meets the criteria for exactly one of the provided interventions based on their distinct demographic and clinical risk profiles according to current USPSTF and ACIP guidelines.

Step-by-Step Solution

1
Calculate the cumulative smoking exposure for the 54-year-old man.
He has a 30 pack-year history and quit 8 years ago, meeting the strict USPSTF criteria (age 50-80, ≥20 pack-years, quit within 15 years) for annual LDCT.
Lung cancer screening eligibility relies on precise age, exposure, and cessation cutoffs.
2
Evaluate the 61-year-old woman's clinical risk factors for osteoporosis.
Her low BMI (19 kg/m²) and heavy alcohol consumption place her at high fracture risk, justifying early screening with dual-energy x-ray absorptiometry (DEXA) before the standard age of 65.
Postmenopausal women under 65 require DEXA only if their estimated 10-year fracture risk exceeds that of an average 65-year-old woman.
3
Determine the current recommended starting age for breast cancer screening.
The 43-year-old average-risk woman should be matched with biennial screening mammography due to the updated 2024 USPSTF guidelines shifting the starting age to 40.
Staying current with guideline updates is essential to avoid delayed preventive care.
4
Identify vaccination indications for the 48-year-old man.
His stage 3 chronic kidney disease acts as a qualifying underlying medical condition for pneumococcal vaccination prior to age 65, making the 20-valent pneumococcal conjugate vaccine the correct match.
Adults aged 19-64 require targeted immunizations based on specific comorbid conditions.

Key Concept

Applying evidence-based preventive screening and immunization guidelines (USPSTF and ACIP) to diverse adult populations based on age, risk factors, and comorbidities.
Question 1074Question →

A 65-year-old man with a 40-pack-year smoking history presents to the clinic for a routine health maintenance visit. He has no symptoms of lung disease. The physician initiates a discussion regarding lung cancer screening with low-dose computed tomography (LDCT) and employs the SHARE approach for shared decision-making. Arrange the following physician statements in the correct sequential order according to the steps of the SHARE protocol.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence follows the AHRQ SHARE approach: Seek participation, Help explore options, Assess values, Reach a decision, and Evaluate the decision.
The SHARE protocol provides a structured framework for shared decision-making. The correct sequence is: 1) Seek your patient's participation, 2) Help your patient explore and compare treatment options, 3) Assess your patient's values and preferences, 4) Reach a decision with your patient, and 5) Evaluate your patient's decision.

Step-by-Step Solution

1
Identify the first step of the SHARE approach, which is 'Seek your patient's participation'.
The physician invites the patient to participate in the decision-making process regarding LDCT.
Establishing a collaborative environment is the foundational first step before discussing clinical details.
2
Identify the second step, 'Help your patient explore and compare treatment options'.
The physician outlines the benefits (reduced mortality) and harms (false positives, invasive testing) of screening.
Patients must understand the clinical evidence and alternatives to make an informed choice.
3
Identify the third step, 'Assess your patient's values and preferences'.
The physician asks how the patient weighs the risks of false positives against the benefits of early detection.
Shared decision-making integrates clinical evidence with the patient's personal risk tolerance and values.
4
Identify the fourth step, 'Reach a decision with your patient'.
The physician and patient agree to proceed with the LDCT scan based on the patient's stated preferences.
A concrete clinical plan must be established once values are aligned with the medical options.
5
Identify the final step, 'Evaluate your patient's decision'.
The physician sets a follow-up plan to review the results and reassess the screening strategy in the future.
Medical decisions, especially preventive screenings, should be revisited to ensure they still align with the patient's goals.

Key Concept

The SHARE approach is a five-step model established by the Agency for Healthcare Research and Quality (AHRQ) to facilitate shared decision-making in clinical practice.
Question 1075Question →

A 45-year-old man is hospitalized for native mitral valve infective endocarditis due to methicillin-susceptible Staphylococcus aureus. He has been receiving intravenous cefazolin for the past week. He is now afebrile, his surveillance blood cultures are negative, and he is deemed medically stable. The multidisciplinary team decides to transition him to Outpatient Parenteral Antimicrobial Therapy (OPAT) to complete his remaining 5-week course of antibiotics at home. Arrange the following discharge planning and care transition steps in the most appropriate chronological sequence to ensure a safe transition to the home setting.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for an OPAT transition is: 1) Finalize the regimen, 2) Assess psychosocial suitability and obtain venous access, 3) Coordinate home health and pharmacy logistics, 4) Educate the patient and family, and 5) Establish the post-discharge monitoring and follow-up protocol.
According to Infectious Diseases Society of America (IDSA) guidelines for OPAT, the transition process must follow a logical sequence to prevent unsafe discharges and hospital readmissions. The regimen must first be finalized to dictate the type of access and nursing required. Next, the patient's home environment and psychosocial status must be deemed safe, and durable venous access (such as a PICC line) must be secured. Only then can specific home health and pharmacy logistics be effectively coordinated. Patient education follows, tailored to the specific equipment that the external agency will provide. Finally, a strict monitoring plan for weekly laboratory draws and clinical follow-up must be documented before the patient physically leaves the hospital setting.

Step-by-Step Solution

1
Determine the medical requirements
The exact antimicrobial drug, dose, and frequency are finalized.
Without a specific regimen, it is impossible to evaluate if home therapy is practical or which type of venous access is required.
2
Evaluate the patient and secure access
Psychosocial screening is completed and a PICC line is placed.
The patient must have a safe home environment, insurance coverage, and cognitive ability to manage a central line before involving outside agencies.
3
Arrange community services
A home infusion pharmacy and visiting nurse agency are contracted.
External agencies need the exact regimen and confirmation of venous access to accept the patient and prepare the medications.
4
Perform patient education
The patient successfully demonstrates teach-back for infusion mechanics and line care.
Education is most effective when it is specific to the actual equipment the home pharmacy will provide and the specific venous access device placed.
5
Finalize the monitoring handoff
Weekly labs are ordered and the OPAT clinic follow-up is scheduled.
A safe transition requires a concrete plan for tracking therapeutic efficacy and drug toxicity (e.g., bone marrow suppression, renal injury) immediately prior to physical discharge.

Key Concept

The safe transition of a patient to Outpatient Parenteral Antimicrobial Therapy (OPAT) requires a strict, sequential multidisciplinary approach starting with medical stabilization and regimen selection, progressing through psychosocial assessment and access placement, and concluding with care coordination, education, and rigorous follow-up planning.
Question 1076Question →

A 34-year-old woman comes to the clinic to discuss contraception. She is entering a new relationship and requests a prescription for a combined oral contraceptive pill. Her medical history is notable for an unprovoked deep vein thrombosis in her right lower extremity 3 years ago, for which she completed a 6-month course of rivaroxaban. She currently takes no medications and does not smoke. The physician informs the patient that estrogen-containing contraceptives are medically contraindicated due to her history. The patient becomes frustrated and states, "I was on the pill for 10 years before my blood clot without any problems, and I know my own body. I am willing to accept the risk of another clot. It is my body and my choice, so please just write the prescription." Which of the following is the most appropriate response by the physician?

Show answer & explanation

Answer: I hear that you feel comfortable with the pill based on your past experience, but because of your history, it is medically unsafe for me to prescribe it. Let's discuss highly effective alternatives.

Answer

Validate the patient's feelings and past experiences, firmly state the medical contraindication to estrogen to maintain ethical boundaries, and offer safe alternative contraceptive methods.
The correct response effectively manages a challenging patient encounter by utilizing a patient-centered communication strategy while adhering to strict medical guidelines. A history of unprovoked deep vein thrombosis is a Category 4 (absolute) contraindication to combined oral contraceptives according to medical eligibility criteria. Physicians are ethically bound by the principle of non-maleficence and are not obligated to provide treatments that are medically inappropriate or harmful, even if the patient explicitly demands them. The best approach is to empathetically acknowledge the patient's frustration, clearly explain the medical boundary without arguing, and redirect the conversation toward safe, highly effective alternatives.

Step-by-Step Solution

1
Identify the medical contraindication
The patient has a history of unprovoked deep vein thrombosis, making estrogen-containing contraceptives a Category 4 (absolute) contraindication.
Estrogen significantly increases thrombotic risk and providing it violates the ethical principle of non-maleficence.
2
Evaluate the patient's request and ethical boundaries
The patient understands the risks but demands the prescription based on the principle of autonomy.
While patient autonomy grants the right to refuse care, it does not grant the right to demand contraindicated, non-standard, or harmful medical treatments.
3
Formulate the optimal communication strategy
Acknowledge the patient's perspective to maintain the therapeutic alliance, clearly refuse the unsafe prescription without being argumentative, and pivot to discussing safe alternatives (e.g., progestin-only pills, intrauterine devices).
This approach balances empathy with strict adherence to medical safety standards.

Key Concept

Managing patient demands for medically contraindicated treatments by balancing empathetic communication with firm medical boundaries.
Question 1077Question →

Match each patient's clinical presentation and associated risk stratification score with the most appropriate immediate disposition from the Emergency Department.

Click a left item, then click its matching right item

Items

Community-acquired pneumonia in a 68-year-old presenting with new-onset confusion, respiratory rate 34/min, blood pressure 85/55 mmHg, and BUN 24 mg/dL. (CURB-65 Score: 4)
Moderately suspicious chest pain in a 55-year-old patient with hypertension and diabetes. Initial EKG shows non-specific changes; first troponin is normal. (HEART Score: 4)
Acute pulmonary embolism in a hemodynamically stable 42-year-old (HR 85/min, BP 120/80 mmHg, SpO2 98%) lacking significant medical comorbidities. (PESI Class I)
A single episode of melena in a 35-year-old who is hemodynamically stable with hemoglobin 14.5 g/dL, BUN 12 mg/dL, and no history of liver disease. (Glasgow-Blatchford Score: 0)

Matches

Show answer & explanation

Answer

The correct matches align each clinical risk score with its guideline-directed care setting: CURB-65 of 4 requires MICU admission; a HEART score of 4 requires an Observation Unit; PESI Class I allows home discharge with a DOAC; and a Glasgow-Blatchford Score of 0 allows home discharge with outpatient endoscopy.
Each risk stratification tool (CURB-65, HEART, PESI, GBS) has rigorously validated thresholds that dictate specific transitions of care. Recognizing these thresholds prevents both the under-triage of critically ill patients and the over-triage of low-risk patients.

Step-by-Step Solution

1
Evaluate the disposition for the patient with community-acquired pneumonia using the CURB-65 score.
A score of 4 correlates with a high 30-day mortality risk.
Guides the decision for immediate MICU admission to provide advanced hemodynamic and respiratory support.
2
Assess the chest pain patient using the HEART score.
A score of 4 indicates an intermediate risk for acute coronary syndrome.
Mandates placement in an observation unit for serial cardiac biomarker evaluation rather than immediate discharge or full inpatient admission.
3
Determine the appropriate setting for the patient with acute pulmonary embolism utilizing the PESI criteria.
PESI Class I indicates a very low risk of short-term mortality.
Supports safe discharge directly from the emergency department with a DOAC, reducing iatrogenic risks associated with hospitalization.
4
Analyze the upper gastrointestinal bleed presentation utilizing the Glasgow-Blatchford Score (GBS).
A GBS of 0 indicates a near-zero likelihood of requiring hospital intervention.
Confirms that outpatient gastroenterology follow-up is the most appropriate and resource-efficient disposition.

Key Concept

Utilizing validated clinical risk stratification scores to accurately determine the safest and most resource-appropriate care setting transitions from the emergency department.
Question 1078Question →

A physician evaluates a 68-year-old male patient who is visiting the clinic for a general check-up. The patient has a documented medical history of type 2 diabetes mellitus, essential hypertension, and hyperlipidemia, all of which are well-controlled with his current medications.

He is a former heavy smoker. He smoked 1.5 packs of cigarettes daily from age 18 until he successfully quit at age 52. He drinks alcohol occasionally and exercises three times a week. He has no personal history of cardiovascular disease.

A review of his health records shows that he underwent a screening colonoscopy at age 61, which was completely normal. His immunization records indicate he received the 20-valent pneumococcal conjugate vaccine at age 66, a Tdap booster at age 64, and an age-appropriate influenza vaccine two weeks ago. Recent laboratory studies, including a comprehensive metabolic panel, hemoglobin A1c, and a urine albumin-to-creatinine ratio, were performed last month and were all within target ranges.

The patient feels well and has no active complaints. His blood pressure is 126/78 mm Hg, heart rate is 72/min, and BMI is 28 kg/m228\text{ kg/m}^2. Physical examination reveals normal heart sounds, clear lungs bilaterally, and a soft, non-tender abdomen with no palpable masses or bruits.

Based on current guidelines, which of the following is the most appropriate next step in preventive care for this patient?

Show answer & explanation

Answer: One-time abdominal ultrasonography

Answer

One-time abdominal ultrasonography
The correct answer is one-time abdominal ultrasonography. According to the United States Preventive Services Task Force (USPSTF) guidelines, a one-time screening for an abdominal aortic aneurysm (AAA) with ultrasonography is recommended for men aged 65 to 75 years who have a history of smoking (defined as 100100 or more cigarettes in a lifetime). This 68-year-old male has an extensive smoking history and falls directly within the recommended age bracket, making this the most appropriate next step in his preventive care.

Step-by-Step Solution

1
Evaluate the patient's demographic and smoking history against abdominal aortic aneurysm screening guidelines.
The patient is a 68-year-old male who has a significant smoking history (greater than 100 lifetime cigarettes).
Current guidelines recommend a one-time screening ultrasound for men aged 65 to 75 who have ever smoked.
2
Calculate the patient's smoking pack-years and time since quitting to evaluate lung cancer screening indication.
The patient smoked 1.51.5 packs/day for 3434 years (1.5×34=511.5 \times 34 = 51 pack-years). He quit at age 5252, meaning it has been 1616 years since he last smoked (68−52=1668 - 52 = 16).
Lung cancer screening requires an annual low-dose chest CT for adults aged 50 to 80 with at least a 20 pack-year history, provided they currently smoke or quit within the past 15 years. Since he quit 16 years ago, he does not meet the criteria.
3
Review the timeline of previous preventive interventions.
His last colonoscopy was normal 7 years ago (due in 3 years). All required vaccinations for his age and comorbidities are up to date.
This confirms that other routine screenings or immunizations are not immediately indicated.

Key Concept

The USPSTF recommends a one-time screening for abdominal aortic aneurysm (AAA) with ultrasonography in men aged 65 to 75 years who have ever smoked. Conversely, lung cancer screening with low-dose CT should be discontinued once a patient has not smoked for 15 years.
Question 1079Question →

A 45-year-old man presents to the outpatient clinic for a routine health maintenance visit. His blood pressure is 138/86 mm Hg and his heart rate is 76/min. The physician is preparing to initiate a structured tobacco cessation intervention utilizing the United States Preventive Services Task Force (USPSTF) recommended "5 A's" clinical protocol. Arrange the following physician statements in the correct chronological sequence to appropriately execute this framework.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Inquire about tobacco use, 2) Strongly urge the patient to quit, 3) Determine readiness to quit, 4) Offer treatment options, and 5) Schedule follow-up.
The correct sequence exactly follows the USPSTF '5 A's' framework for tobacco cessation counseling. The physician must first Ask about tobacco use to establish the behavior. Next, they must Advise the patient to quit using clear and personalized medical language. Following the advice, the physician Assesses the patient's readiness to change. If the patient is ready, the physician Assists by offering evidence-based pharmacotherapy and behavioral counseling. Finally, the physician Arranges follow-up to support the quit attempt and monitor for relapse.

Step-by-Step Solution

1
Identify the clinical protocol being tested.
The scenario requires application of the USPSTF '5 A's' behavioral counseling framework for tobacco cessation.
Recognizing the framework provides the necessary structure to order the clinical statements accurately.
2
Map each physician statement to its corresponding 'A' in the framework.
Inquiring about use maps to 'Ask'; urging cessation maps to 'Advise'; determining readiness maps to 'Assess'; offering prescriptions maps to 'Assist'; scheduling a return visit maps to 'Arrange'.
Categorizing the dialogue allows for proper chronological sequencing.
3
Order the mapped statements according to the evidence-based protocol sequence.
The correct order is Ask, Advise, Assess, Assist, Arrange.
This sequence ensures the physician identifies the problem, provides medical recommendation, evaluates patient autonomy and readiness, provides actionable help, and ensures continuity of care.

Key Concept

The 5 A's Behavioral Counseling Framework for Tobacco Cessation
Question 1080Question →

A 74-year-old man with end-stage idiopathic pulmonary fibrosis is receiving home hospice care. He develops an acute, severe episode of dyspnea at rest, accompanied by marked distress and tachypnea. He is already receiving supplemental oxygen. Arrange the following palliative interventions for terminal dyspnea in the most appropriate stepwise order of escalation, from the initial measure (first) to the intervention of last resort (last).

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with non-pharmacologic measures, proceeds to systemic opioids, then adds benzodiazepines for refractory anxiety, and finally culminates in palliative sedation if symptoms become entirely intractable.
The proper stepwise management of terminal dyspnea begins with non-pharmacologic optimization, followed by systemic opioids as the primary pharmacologic agent. If symptoms or associated anxiety persist, benzodiazepines are added as an adjunct. Finally, if the dyspnea remains refractory and intolerable despite maximal therapy, palliative sedation is initiated as the treatment of last resort.

Step-by-Step Solution

1
Implement immediate non-pharmacologic interventions.
The patient is repositioned, and a cool fan is directed at his face.
Non-pharmacologic measures carry the lowest risk and can be implemented instantly to provide initial subjective relief.
2
Administer first-line pharmacologic therapy for terminal dyspnea.
Systemic opioids (e.g., morphine) are administered.
Opioids are the gold standard for relieving dyspnea in advanced disease because they reduce respiratory drive and alter the central perception of breathlessness.
3
Reassess the patient for residual symptoms, specifically focusing on panic or anxiety.
A benzodiazepine is added to the regimen if significant distress persists.
Anxiety often exacerbates dyspnea. Benzodiazepines serve as effective adjuncts when opioids are not fully effective at completely mitigating the panic component.
4
Determine if the patient's symptoms are completely refractory to maximum tolerated medical therapy.
Palliative sedation is initiated as a final measure.
When all conventional therapies fail and the patient is suffering intolerably at the end of life, proportionate sedation is ethically and medically indicated.

Key Concept

The stepwise escalation of therapy for refractory dyspnea at the end of life prioritizes non-pharmacologic interventions and opioids, followed by benzodiazepines for anxiety, and palliative sedation strictly as a last resort.

Alternative Method

In some rapidly escalating scenarios (e.g., acute catastrophic hemorrhage or massive pulmonary embolism in a dying patient), steps may be compressed, and providers may move directly from opioids to sedation, but the general hierarchy of preference remains identical.
Estimated Time:1m 0s
PreviousPage 54 / 104Next
Patient Management Practice Questions — USMLE Step 3 — Page 54 | Examkin